2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase

Christopher J. Matheson, Christopher R. Coxon, Richard Bayliss, Kathy Boxall, Benoit Carbain, Andrew M. Fry, Ian R. Hardcastle, Suzannah J. Harnor, Corine Mas-Droux, David R. Newell, Mark W. Richards, Mangaleswaran Sivaprakasam, David Turner, Roger J. Griffin, Bernard T. Golding and Céline Cano

RSC Med. Chem., 2020, 11, 707
DOI: 10.1039/D0MD00074D

Correlations and statistical analysis of solvent molecule hydrogen bonding – a case study of dimethyl sulfoxide (DMSO)

L. Spiteri, U. Baisch and L. Vella-Zarb

CrystEngComm, 2018, 20, 1291
DOI: 10.1039/C7CE02206A

A new tool for the chemical genetic investigation of the Plasmodium falciparum Pfnek-2 NIMA-related kinase

Deborah F. Mitcheson, Andrew R. Bottrill, Katherine Carr, Christopher R. Coxon, Celine Cano, Bernard T. Golding, Roger J. Griffin, Andrew M. Fry, Christian Doerig, Richard Bayliss and Andrew B. Tobin

Malar J, 2016, 15
DOI: 10.1186/s12936-016-1580-3

Targeting NEK2 as a promising therapeutic approach for cancer treatment

Yanfen Fang and Xiongwen Zhang

Cell Cycle, 2016, 15, 895
DOI: 10.1080/15384101.2016.1152430

N-Acylamino Saccharin as an Emerging Cysteine-Directed Covalent Warhead and Its Application in the Identification of Novel FBPase Inhibitors toward Glucose Reduction

Wuqiang Wen, Hongxuan Cao, Yixiang Xu, Yanliang Ren, Li Rao, Xubo Shao, Han Chen, Lixia Wu, Jiaqi Liu, Chen Su, Chao Peng, Yunyuan Huang and Jian Wan

J. Med. Chem., 2022, 65, 9126
DOI: 10.1021/acs.jmedchem.2c00336

An Activity‐Based Probe Targeting Non‐Catalytic, Highly Conserved Amino Acid Residues within Bromodomains

Melissa D'Ascenzio, Kathryn M. Pugh, Rebecca Konietzny, Georgina Berridge, Cynthia Tallant, Shaima Hashem, Octovia Monteiro, Jason R. Thomas, Markus Schirle, Stefan Knapp, Brian Marsden, Oleg Fedorov, Chas Bountra, Benedikt M. Kessler and Paul E. Brennan

Angew Chem Int Ed, 2019, 58, 1007
DOI: 10.1002/anie.201807825

An Activity‐Based Probe Targeting Non‐Catalytic, Highly Conserved Amino Acid Residues within Bromodomains

Melissa D'Ascenzio, Kathryn M. Pugh, Rebecca Konietzny, Georgina Berridge, Cynthia Tallant, Shaima Hashem, Octovia Monteiro, Jason R. Thomas, Markus Schirle, Stefan Knapp, Brian Marsden, Oleg Fedorov, Chas Bountra, Benedikt M. Kessler and Paul E. Brennan

Angewandte Chemie, 2019, 131, 1019
DOI: 10.1002/ange.201807825

Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development

Dibyendu Dana, Tuhin Das, Athena Choi, Ashif I. Bhuiyan, Tirtha K. Das, Tanaji T. Talele and Sanjai K. Pathak

Molecules, 2022, 27, 347
DOI: 10.3390/molecules27020347

Comparative reactivity profiling of cysteine-specific probes by chemoproteomics

Fan Yang, Nan Chen, Fengzhang Wang, Guogeng Jia and Chu Wang

Current Research in Chemical Biology, 2022, 2, 100024
DOI: 10.1016/j.crchbi.2022.100024

Comprehensive proteomics analysis reveals novel Nek2-regulated pathways and therapeutic targets in cancer

Batuhan Mert Kalkan, Ahmet Tarik Baykal, Enes Cicek and Ceyda Acilan

Biochemical and Biophysical Research Communications, 2024, 734, 150779
DOI: 10.1016/j.bbrc.2024.150779

NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1

Xiaozhen Zhang, Xing Huang, Jian Xu, Enliang Li, Mengyi Lao, Tianyu Tang, Gang Zhang, Chengxiang Guo, Xiaoyu Zhang, Wen Chen, Dipesh Kumar Yadav, Xueli Bai and Tingbo Liang

Nat Commun, 2021, 12
DOI: 10.1038/s41467-021-24769-3

Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors

Kirsten McAulay, Emily A. Hoyt, Morgan Thomas, Marianne Schimpl, Michael S. Bodnarchuk, Hilary J. Lewis, Derek Barratt, Deepa Bhavsar, David M. Robinson, Michael J. Deery, Derek J. Ogg, Gonçalo J. L. Bernardes, Richard A. Ward, Michael J. Waring and Jason G. Kettle

J. Am. Chem. Soc., 2020, 142, 10358
DOI: 10.1021/jacs.9b13391

Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors

Lei Chen, Heng Lu, Farah Ballout, Wael El-Rifai, Zheng Chen, Ravindran Caspa Gokulan, Oliver Gene McDonald and Dunfa Peng

IJMS, 2025, 26, 1992
DOI: 10.3390/ijms26051992

Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices

Abdul-Quddus Kehinde Oyedele, Abdeen Tunde Ogunlana, Ibrahim Damilare Boyenle, Ayodeji Oluwadamilare Adeyemi, Temionu Oluwakemi Rita, Temitope Isaac Adelusi, Misbaudeen Abdul-Hammed, Oluwabamise Emmanuel Elegbeleye and Tope Tunji Odunitan

Mol Divers, 2023, 27, 1879
DOI: 10.1007/s11030-022-10523-4

Role of NEK2A in Human Cancer and Its Therapeutic Potentials

Jiliang Xia, Reinaldo Franqui Machin, Zhimin Gu and Fenghuang Zhan

BioMed Research International, 2015, 2015, 1
DOI: 10.1155/2015/862461

The Greatwall kinase safeguards the genome integrity by affecting the kinome activity in mitosis

Xavier Bisteau, Joann Lee, Vinayaka Srinivas, Joanna H. S. Lee, Joanna Niska-Blakie, Gifford Tan, Shannon Y. X. Yap, Kevin W. Hom, Cheng Kit Wong, Jeongjun Chae, Loo Chien Wang, Jinho Kim, Giulia Rancati, Radoslaw M. Sobota, Chris S. H. Tan and Philipp Kaldis

Oncogene, 2020, 39, 6816
DOI: 10.1038/s41388-020-01470-1

Study of mangal based naphthoquinone derivatives anticancer potential towards chemo-resistance related Never in mitosis gene A-related kinase 2-Insilico approach

K. Archana Vasuki, H. Jemmy Christy, Vivek Chandramohan and Daniel Alex Anand

Molecular Simulation, 2021, 47, 1078
DOI: 10.1080/08927022.2021.1948545

Requirement of Nek2a and cyclin A2 for Wapl-dependent removal of cohesin from prophase chromatin

Susanne Hellmuth and Olaf Stemmann

EMBO J, 2024, 43, 5237
DOI: 10.1038/s44318-024-00228-9

Characterising covalent warhead reactivity

James S. Martin, Claire J. MacKenzie, Daniel Fletcher and Ian H. Gilbert

Bioorganic & Medicinal Chemistry, 2019, 27, 2066
DOI: 10.1016/j.bmc.2019.04.002

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update

Laura Hillebrand, Xiaojun Julia Liang, Ricardo A. M. Serafim and Matthias Gehringer

J. Med. Chem., 2024, 67, 7668
DOI: 10.1021/acs.jmedchem.3c01825